Acute hepatitis C infection: an indication for alfa interferon therapy?
van der Vlies
C H
CH
Department of Hepatogastroenterology, Room Ca 326, Erasmus University Hospital Rotterdam, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
Tang
T J
TJ
Niesters
H G
HG
Zondervan
P E
PE
Janssen
H L
HL
de Man
R A
RA
D000208:Acute Disease; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003815:Dentists; D004305:Dose-Response Relationship, Drug; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D006526:Hepatitis C / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy* / Q000635:transmission; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009784:Occupational Diseases / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*; D012367:RNA, Viral / Q000097:blood; D016896:Treatment Outcome
D000998:Antiviral Agents; D018937:Hepatitis C Antibodies; D016898:Interferon-alpha; D012367:RNA, Viral